Search
for
Sort by
Research 661–690 of 1000+
- Pharmacologic inhibition of JAK-STAT signaling promotes hair growth
- Off-Label Uses of Abrocitinib: Review of Emerging Therapeutic Applications beyond Atopic Dermatitis
- A clinician’s guide to pediatric and adolescent alopecia areata treatments
- PRP for Immune Mediated Alopecias (Alopecia Areata, Alopecia Totalis)
- Stem cell-based therapies for alopecia areata: a narrative review
- Review of Promising Off-Label Use of Deucravacitinib
- Abrocitinib in the Treatment of Severe Alopecia Areata in a Pediatric Patient: A Case Report
- Successful treatment of severe atopic dermatitis and alopecia universalis with upadacitinib in a 29-year-old male patient
- APECED: JAK Inhibition in an Adult Case with Long-Term Follow-up
- Successful treatment of severe diffuse alopecia areata with abrocitinib
- Significant efficacy of tofacitinib from China in the treatment of alopecia areata: a case report
- Baricitinib (Olumiant)
- Baricitinib as a treatment for myasthenia gravis: A case report
- Autoinmune Alopecia/Alopecia Areata
- Upadacitinib for the treatment of alopecia areata – A case report
- The Role of Interferon-γ in Autoimmune Polyendocrine Syndrome Type 1
- Effectiveness and safety of baricitinib in patients with severe alopecia areata: a 36-week multicenter real-world experience
- Alopecia areata treatment with baricitinib: different relapse phenotypes
- 0480 Upadacitinib monotherapy for treatment of pyoderma gangrenosum: A case series
- Baricitinib Effectiveness in JAKi‐Naïve and Tofacitinib‐Exposed Patients: A Prospective Study in Alopecia Areata
- S3886 Concurrent Management of Crohn's Ileitis and Alopecia Universalis With Upadacitinib
- Safety and efficacy of tofacitinib in 97 alopecia areata patients
- Efficacy of JAK 1/2 inhibition in the treatment of diffuse non-scarring alopecia due to systemic lupus erythematosus
- Baricitinib in pediatric chronic immune thrombocytopenia and associated autoimmune conditions: a case report
- Efficacy of Barictinib As Compared to Conventional Therapy as a Treatment for Alopecia Areata
- Application of Baricitinib in Dermatology
- Biologics and Small Molecules for Inflammatory Nail Disorders: A Narrative Review
- 42004 Scalp, eyebrow, and eyelash hair regrowth with continued ritlecitinib treatment among patients with alopecia areata without target efficacy response at Week 24: post hoc analysis of the ALLEGRO phase 2b/3 study
- BH15 Efficacy and safety of baricitinib in the management of severe alopecia areata over a 6-month period: a real-world experience
- Editorial: Targeted immunological therapies in dermatology